New York State Common Retirement Fund’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-63
Closed 3582
2021
Q2
$0 Sell
63
-8,637
-99% -$46.6K ﹤0.01% 3586
2021
Q1
$51K Hold
8,700
﹤0.01% 3217
2020
Q4
$40K Hold
8,700
﹤0.01% 3215
2020
Q3
$34K Hold
8,700
﹤0.01% 3186
2020
Q2
$250K Buy
8,700
+3,200
+58% +$74.1K ﹤0.01% 2548
2020
Q1
$118K Hold
5,500
﹤0.01% 2701
2019
Q4
$108K Buy
+5,500
New +$78.2K ﹤0.01% 2983

Other funds holding STSA

New York State Common Retirement Fund's STSA Position: Q3 2021 in Review

New York State Common Retirement Fund sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q3 2021, closing a stake of 63 shares.

New York State Common Retirement Fund first reported a position in STSA in Q4 2019 and held it in 7 quarters. The position peaked at $250K in Q2 2020. 45 funds tracked by Wall St. Rank hold STSA as of Q3 2021.

  • New York State Common Retirement Fund reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • New York State Common Retirement Fund sold 63 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q3 2021.
  • New York State Common Retirement Fund first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 7 quarters.
  • New York State Common Retirement Fund's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $250K in Q2 2020.
  • 45 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q3 2021.

Based on New York State Common Retirement Fund's 13F filing for Q3 2021, filed 2 Nov 2021.